Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Wu
    Wu
  10. Wolden
    Wolden

Groups

  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)
  7. Center for Hematologic Malignancies (1674)
  8. Hematologic Malignancies, Division of (1609)
  9. Gynecology Disease Management Team (1425)
  10. Sloan Kettering Institute Faculty (1413)
Search Within
Formats
  1. Journal Article (7387)
  2. Meeting Abstract (4694)
  3. Review (616)
  4. Book Section (538)
  5. Editorial (250)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (240)
  2. 2024 (784)
  3. 2023 (762)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2610)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (524)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13855)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study of REGN5093-M114, a METxMET antibody-drug conjugate, in patients with MET-overexpressing NSCLC
    Meeting Abstract

    Drilon, A.; Awad, M. M.; Camidge, D. R.; Forde, P. M.; Alexander, M.; Gadgeel, S. M.; Villaruz, L. C.; Perez, J.; Navas, T.; Daly, C.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Standardized screening of thoracic oncology patients for clinical trial eligibility increases enrollment
    Meeting Abstract

    Cislo, M. A.; Mcmillan, M.; Shaverdian, N.; Simone, C.; Gelblum, D.; Khan, A.; Rimner, A.; Burleigh, A.; Navarro, K.; Spielsinger, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Frequency and outcomes of leptomeningeal metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Chen, M.; Sui, J.; Wilcox, J.; Yang, S. R.; Imber, B.; Offin, M.; Yu, H.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Radiotheranostics targeting Delta-like ligand 3 expressing small-cell lung cancers
    Meeting Abstract

    Tendler, S.; Hoang, T.; Bauer, D.; Korsen, J.; Carter, L.; Michel, A.; Degregorio, R.; Pillarsetty, N.; Poirier, J. T.; Lewis, J. S.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Tepotinib in Asian patients with MET exon 14 skipping non-small cell lung cancer (NSCLC) in long-term follow-up from VISION
    Meeting Abstract

    Ahn, M. J.; Kato, T.; Yang, J. C. H.; Sakai, H.; Morise, M.; Chen, Y. M.; Han, J. Y.; Yang, J. J.; Zhao, J.; Hsia, T. C.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Beware: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to "False" decreases in renal function
    Meeting Abstract

    Chen, M.; Harada, G.; Liu, D.; Dematteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Genomic correlates with ancestry in lung squamous cell carcinoma
    Meeting Abstract

    Jain, S.; Yao, A.; Allen-Gipson, D.; Momen-Heravi, F.; Zhang, X.; Carrot-Zhang, J.; Taylor, A. M.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2 study of ifinatamab deruxtecan (I-DXd; DS-7300) in patients with previously treated ES-SCLC
    Meeting Abstract

    Rudin, C.; Johnson, M.; Girard, N.; Hann, C. L.; Ahn, M. J.; Nishio, M.; Godard, J.; Arca, M.; Qian, M.; Singh, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Brain metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Sui, J. S.; Chen, M. F.; Wilcox, J.; Yang, S. R.; Li, B. T.; Riely, G. J.; Offin, M.; Yu, H. A.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in patients with ALK+ NSCLC and ALK-inhibitor resistance
    Meeting Abstract

    Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save